Monoclonal B cells detected in autologous PBSC grafts from patients with classical Hodgkin lymphoma: impact on relapse and survival following transplantation

[1]  M. Siedner,et al.  Circulating clonotypic B cells in classic Hodgkin lymphoma. , 2009, Blood.

[2]  S. le Cessie,et al.  Long‐term follow‐up of a population based cohort with monoclonal proteinaemia , 2009, British journal of haematology.

[3]  T. Usa,et al.  Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders , 2008, Journal of endocrinological investigation.

[4]  Y. Oki,et al.  Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma , 2008, Cancer.

[5]  J. Olsen,et al.  Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. , 2006, Journal of the National Cancer Institute.

[6]  G. M. Taylor,et al.  Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. , 2005, Blood.

[7]  P. Mclaughlin,et al.  A pilot study of rituximab in patients with recurrent, classic Hodgkin disease , 2003, Cancer.

[8]  T. McDonnell,et al.  BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. , 2002, Blood.

[9]  R. Moog,et al.  Concurrent collection of in-line filtered platelets and red blood cells by apheresis , 2002, Annals of Hematology.

[10]  A. Marx,et al.  Autoimmune lymphoproliferative syndrome associated with severe humoral immunodeficiency and monoclonal gammopathy , 2002, Annals of Hematology.

[11]  G. Bonadonna,et al.  CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Terry M Therneau,et al.  A long-term study of prognosis in monoclonal gammopathy of undetermined significance. , 2002, The New England journal of medicine.

[13]  T. McDonnell,et al.  BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  M. Kvarnström,et al.  Myelin protein P0‐specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS) , 2002, Clinical and experimental immunology.

[15]  A. López-Guillermo,et al.  Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Armitage,et al.  Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR) , 2001, Bone Marrow Transplantation.

[17]  H. Stein,et al.  Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. , 2000, Blood.

[18]  J. Armitage,et al.  A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. , 1998, The New England journal of medicine.

[19]  V. Diehl,et al.  Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease. , 1998, Blood.

[20]  A. Goldstone,et al.  High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT , 1997, Bone Marrow Transplantation.

[21]  R. Bouabdallah,et al.  Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry , 1997, Bone Marrow Transplantation.

[22]  S. Horning,et al.  High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. , 1997, Blood.

[23]  C. von Kalle,et al.  Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. , 1996, Blood.

[24]  S. Pileri,et al.  Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. , 1995, The New England journal of medicine.

[25]  R Fischer,et al.  Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Vnencak-Jones,et al.  Determination of B-cell clonality in paraffin-embedded endoscopic biopsy specimens of abnormal lymphocytic infiltrates and gastrointestinal lymphoma by polymerase chain reaction. , 1994, American journal of clinical pathology.

[27]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[28]  W. Chan,et al.  Detection and Relevance of Minimal Disease in Lymphomas , 2004, Cancer and Metastasis Reviews.

[29]  M. Andreeff,et al.  Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease , 2002, Cancer.